SCHEMBL14547181

SCHEMBL14547181

CCN1CCN(c2ccc(Nc3nc(C)c4cc(/C(N)=C/C=N)c(=O)n(C5CCOCC5)c4n3)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 19/20 0.48
CCND1 P24385 18/20 0.48
CDK2 P24941 9/20 0.48
CDK6 Q00534 5/20 0.48
CCNE1 P24864 2/20 0.48
CCNT1 O60563 1/20 0.48
CDK9 P50750 1/20 0.48
CCND2 P30279 8/20 0.44
CCND3 P30281 8/20 0.44
CCNB2 O95067 2/20 0.43
CDK1 P06493 2/20 0.43
CCNB1 P14635 2/20 0.43
CCNB3 Q8WWL7 2/20 0.43
CCNA2 P20248 8/20 0.42
FGFR1 P11362 6/20 0.42
FGFR2 P21802 6/20 0.42
FGFR4 P22455 6/20 0.42
FGFR3 P22607 6/20 0.42
CCNA1 P78396 2/20 0.41
CCNE2 O96020 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14547323 0.96 CDK4 (0.44) CDK4CCND1CDK2CDK6CCNE1
SCHEMBL14547180 0.93 CDK4 (0.54) CDK4CCND1CDK2CDK6CCNE1
SCHEMBL4227763 0.84 CDK4 (0.51) CDK4CCND1CDK2CDK6CCNE1
SCHEMBL4220812 0.80 PIK3CA (0.56) CDK4CCND1CDK2CDK6CCNE1
SCHEMBL4226220 0.79 PIK3CA (0.49) CDK4CCND1CDK2CDK6CCNE1
SCHEMBL12102037 0.78 CDK4 (0.46) CDK4CCND1CDK2CDK6CCNE1
SCHEMBL3337709 0.77 CDK4 (0.59) CDK4CCND1CDK2CDK6CCNE1
SCHEMBL4225857 0.76 PIK3CA (0.45) CDK4CCND1CDK2CDK6CCNE1
SCHEMBL4222668 0.76 PIK3CA (0.45) CDK4CCND1CDK2CDK6CCNE1
SCHEMBL4232744 0.76 PIK3CA (0.45) CDK4CCND1CDK2CDK6CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007044698-A1 PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα EXELIXIS, INC. (US) 2007-04-19 WO disclosed